Global Health Limited (Medanta) has submitted a regulatory disclosure to BSE Limited and National Stock Exchange of India Limited regarding its scheduled earnings conference call for Q1 FY2027 results.

The disclosure is made pursuant to Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Event Details

  • Event Type: Earnings Conference Call for Q1 FY2027 financial results
  • Date: Friday, July 31, 2026
  • Time: 02:00 P.M. IST (4:30 AM USA EST | 9:30 AM UK Time | 4:30 PM HK/Singapore Time)
  • Host: JM Financial
  • Period Covered: First Quarter ended June 30, 2026

Management Participants

The conference call will feature the following management representatives:

  • Dr. Naresh Trehan – Chairman & Managing Director
  • Mr. Pankaj Sahni – Group CEO & Director
  • Mr. Yogesh Kumar Gupta – Chief Financial Officer
  • Mr. Gaurav Chugh – Head Investor Relations

Dial-in Information

  • Universal Dial In: +91-22-7195 0000
  • Toll Free Numbers:
  • Singapore: 800 101 1997
  • Hong Kong: 800 900 919
  • USA: 1 877 271 3944
  • UK: 0 808 101 1132

Participants are advised to register in advance using the provided link for zero wait time connection.

Company Background

The document provides background information on Global Health Limited:

  • Founded by Dr. Naresh Trehan, a world-renowned cardiovascular and cardiothoracic surgeon
  • Dr. Trehan has been awarded Padma Bhushan, Padma Shri, and Dr. B.C. Roy Award
  • One of the largest private multi-specialty tertiary care providers in North and East India
  • Key specialties include cardiac science, neurosciences, oncology, digestive and hepatobiliary sciences, orthopedics, liver transplant, and kidney and urology

Operational Details

  • Brand: Medanta
  • Operational Hospitals: 6 (Gurgaon, Indore, Ranchi, Lucknow, Patna, Noida)
  • Total Area: 5.6 million sq.ft.
  • Installed Beds: 3,665 as on March 31, 2026
  • Upcoming Hospitals: 5 (Mumbai, Guwahati, Varanasi, and two hospitals in Delhi)
  • Medical Specialties: Over 30 specialties
  • Doctors: Over 2,400+ doctors led by highly experienced department heads

The document is signed by Rahul Ranjan, Company Secretary & Compliance Officer (M. No. A17035) on July 24, 2026, at 17:55:47 IST.